Literature DB >> 18830614

Axonal protection by brain-derived neurotrophic factor associated with CREB phosphorylation in tumor necrosis factor-alpha-induced optic nerve degeneration.

Hiromi Fujino1, Yasushi Kitaoka, Yasuhiro Hayashi, Yasunari Munemasa, Hiroyuki Takeda, Toshio Kumai, Shinichi Kobayashi, Satoki Ueno.   

Abstract

Brain-derived neurotrophic factor (BDNF) is a potent survival and developmental factor that is regulated by cyclic AMP-response element binding protein (CREB) and has a protective effect against retinal ganglion cell (RGC) death. However, the effect of BDNF on the optic nerve axonal degeneration remains to be examined. In this study, we show that intravitreal injection of tumor necrosis factor (TNF)-alpha induces transient increases in phosphorylated-CREB (p-CREB) and BDNF expression in the optic nerve. Administration of exogenous BDNF further increased the p-CREB and endogenous BDNF level and exerted a neuroprotective effect against TNF-alpha-induced axonal loss. The increases in BDNF mRNA and protein induced by TNF-alpha were inhibited significantly by a CRE decoy oligonucleotide. The protective effect of exogenous BDNF on axons was also inhibited by the CRE decoy oligonucleotide. These results suggest that the protective effect of exogenous BDNF may be associated with increases in CREB phosphorylation and endogenous BDNF in the optic nerve.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830614     DOI: 10.1007/s00401-008-0440-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  TRPC6: an underlying target for human glaucoma.

Authors:  Qian Fan; Wen-Bin Huang; Xiu-Lan Zhang
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

2.  Inhibition of miR-134 Protects Against Hydrogen Peroxide-Induced Apoptosis in Retinal Ganglion Cells.

Authors:  Yi Shao; Yao Yu; Qiong Zhou; Cheng Li; Lu Yang; Chong-Gang Pei
Journal:  J Mol Neurosci       Date:  2015-03-06       Impact factor: 3.444

3.  Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease.

Authors:  W Swardfager; N Herrmann; S Marzolini; M Saleem; P Shammi; P I Oh; P R Albert; M Daigle; A Kiss; K L Lanctôt
Journal:  Brain Behav Immun       Date:  2011-04-30       Impact factor: 7.217

4.  Injectable Neurotrophic Factor Delivery System Supporting Retinal Ganglion Cell Survival and Regeneration Following Optic Nerve Crush.

Authors:  Melissa R Laughter; James R Bardill; David A Ammar; Brisa Pena; David J Calkins; Daewon Park
Journal:  ACS Biomater Sci Eng       Date:  2018-07-23

5.  An epigenetic association analysis of childhood trauma in psychosis reveals possible overlap with methylation changes associated with PTSD.

Authors:  Solveig Løkhammer; Anne-Kristin Stavrum; Tatiana Polushina; Monica Aas; Akiah A Ottesen; Ole A Andreassen; Ingrid Melle; Stephanie Le Hellard
Journal:  Transl Psychiatry       Date:  2022-04-30       Impact factor: 7.989

6.  Optineurin E50K triggers BDNF deficiency-mediated mitochondrial dysfunction in retinal photoreceptor cell line.

Authors:  Myoung Sup Shim; Keun-Young Kim; Mark Noh; Ji Yoon Ko; Sangphil Ahn; Michelle A An; Takeshi Iwata; Guy A Perkins; Robert N Weinreb; Won-Kyu Ju
Journal:  Biochem Biophys Res Commun       Date:  2018-08-09       Impact factor: 3.575

7.  Effect of δ-opioid receptor activation on BDNF-TrkB vs. TNF-α in the mouse cortex exposed to prolonged hypoxia.

Authors:  Xuesong Tian; Fei Hua; Harleen K Sandhu; Dongman Chao; Gianfranco Balboni; Severo Salvadori; Xiaozhou He; Ying Xia
Journal:  Int J Mol Sci       Date:  2013-07-31       Impact factor: 5.923

8.  Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection.

Authors:  Yasunari Munemasa; Yasushi Kitaoka
Journal:  Front Cell Neurosci       Date:  2013-01-09       Impact factor: 5.505

9.  Neuroprotective activity of peripherally administered liver growth factor in a rat model of Parkinson's disease.

Authors:  Rafael Gonzalo-Gobernado; Lucía Calatrava-Ferreras; Diana Reimers; Antonio Sánchez Herranz; Macarena Rodríguez-Serrano; Cristina Miranda; Adriano Jiménez-Escrig; Juan José Díaz-Gil; Eulalia Bazán
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

10.  Mitochondrial pathogenic mechanism and degradation in optineurin E50K mutation-mediated retinal ganglion cell degeneration.

Authors:  Myoung Sup Shim; Yuji Takihara; Keun-Young Kim; Takeshi Iwata; Beatrice Y J T Yue; Masaru Inatani; Robert N Weinreb; Guy A Perkins; Won-Kyu Ju
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.